Hosted on MSN1mon
RAD51 biomarker could complement next-generation sequencing in personalizing prostate cancer treatment
Patients with RAD51-low scores experienced longer progression free survival (PFS) on treatment with PARP inhibitors or platinum chemotherapy. "Our results demonstrate the feasibility of using the ...
Hosted on MSN2mon
RAD51 testing shows promise in personalized early breast cancer treatment
80% presented RAD51 protein levels correlating with functional HRD. The pCR rate in patients treated with the PARP inhibitor who had HRD by RAD51 was 66.7%. This decreased to 22.2% in patients ...